Postbariatric Hypoglycemia
📧 Sign up to get email alerts when something new happens for Postbariatric Hypoglycemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?
The trial investigates cortisol metabolism in the context of obesity and postbariatric hypoglycemia and how these factors may interact after…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions [Phase 2]
Phase 2 study assessing repeat dosing of Mizagliflozin and its impact on adverse events and postprandial glucose excursions in individuals w…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI) [Phase 2]
MBX Biosciences is conducting a Phase 2 trial to evaluate the efficacy and dose response of Imapextide (STEADI) for postbariatric hypoglycem…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects [Phase 1]
This clinical trial update describes a Phase 1 study of MBX 1416 in healthy subjects to assess safety, tolerability, pharmacokinetics and ph…
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia [Phase 2]
Phase 2 trial assessing safety and efficacy of Exendin 9-39 for postbariatric hypoglycemia has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.